Petrus Trust Company LTA Buys New Position in Plexus Corp. $PLXS

Key Points

• Petrus Trust Company LTA purchased 4,303 shares of Plexus Corp. valued at approximately $551,000, marking a significant investment in the technology company during the first quarter.
• Plexus Corp. reported earnings per share of $1.90 for the last quarter, exceeding analysts' estimates of $1.71 and reflecting a 6.0% increase in revenue year-over-year.
• Several brokerages have adjusted their price targets for Plexus, with Sidoti upgrading it from "neutral" to "buy" and setting a new price target of $150.00.

Petrus Trust Company LTA bought a new stake in Plexus Corp. (NASDAQ:PLXS - Free Report) during the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The fund bought 4,303 shares of the technology company's stock, valued at approximately $551,000.

Other institutional investors have also modified their holdings of the company. Versant Capital Management Inc increased its holdings in shares of Plexus by 1,000.0% in the 1st quarter. Versant Capital Management Inc now owns 473 shares of the technology company's stock valued at $61,000 after acquiring an additional 430 shares during the period. TD Private Client Wealth LLC increased its stake in Plexus by 185.6% in the 1st quarter. TD Private Client Wealth LLC now owns 514 shares of the technology company's stock valued at $66,000 after buying an additional 334 shares during the period. Banque Transatlantique SA acquired a new position in Plexus in the 1st quarter valued at $71,000. N.E.W. Advisory Services LLC acquired a new position in Plexus in the 1st quarter valued at $87,000. Finally, Blue Trust Inc. increased its stake in Plexus by 49.2% in the 1st quarter. Blue Trust Inc. now owns 846 shares of the technology company's stock valued at $108,000 after buying an additional 279 shares during the period. 94.45% of the stock is owned by institutional investors and hedge funds.

Insiders Place Their Bets

In related news, CEO Todd P. Kelsey sold 1,500 shares of the business's stock in a transaction dated Tuesday, September 2nd. The shares were sold at an average price of $134.54, for a total value of $201,810.00. Following the sale, the chief executive officer directly owned 70,714 shares in the company, valued at $9,513,861.56. The trade was a 2.08% decrease in their position. The transaction was disclosed in a filing with the Securities & Exchange Commission, which is available at this hyperlink. Also, insider Victor (Pang Hau) Tan sold 3,000 shares of the business's stock in a transaction dated Thursday, August 28th. The stock was sold at an average price of $139.00, for a total transaction of $417,000.00. Following the completion of the sale, the insider owned 8,723 shares in the company, valued at $1,212,497. This represents a 25.59% decrease in their ownership of the stock. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 14,356 shares of company stock worth $1,926,890. 1.76% of the stock is owned by company insiders.

Analyst Ratings Changes

Several equities analysts have issued reports on PLXS shares. Sidoti raised shares of Plexus from a "neutral" rating to a "buy" rating and boosted their price objective for the company from $135.00 to $150.00 in a research note on Friday, July 25th. Stifel Nicolaus set a $140.00 target price on shares of Plexus in a research report on Thursday, July 24th. Needham & Company LLC decreased their target price on shares of Plexus from $162.00 to $158.00 and set a "buy" rating on the stock in a research report on Thursday, July 24th. Benchmark restated a "buy" rating and set a $160.00 target price on shares of Plexus in a research report on Wednesday, June 4th. Finally, Wall Street Zen lowered shares of Plexus from a "strong-buy" rating to a "buy" rating in a research report on Saturday, August 16th. Three equities research analysts have rated the stock with a Buy rating and two have assigned a Hold rating to the company. According to MarketBeat.com, the stock has a consensus rating of "Moderate Buy" and a consensus target price of $152.00.

Plexus Price Performance

Shares of Plexus stock traded down $2.89 on Friday, hitting $137.90. The company's stock had a trading volume of 51,782 shares, compared to its average volume of 175,318. Plexus Corp. has a 52-week low of $103.43 and a 52-week high of $172.89. The company has a quick ratio of 0.74, a current ratio of 1.58 and a debt-to-equity ratio of 0.06. The firm has a fifty day moving average price of $133.34 and a 200-day moving average price of $129.93. The company has a market capitalization of $3.72 billion, a P/E ratio of 23.49 and a beta of 0.82.

Plexus (NASDAQ:PLXS - Get Free Report) last released its quarterly earnings data on Wednesday, July 23rd. The technology company reported $1.90 EPS for the quarter, topping the consensus estimate of $1.71 by $0.19. Plexus had a net margin of 4.04% and a return on equity of 12.33%. The business had revenue of $1.02 billion for the quarter, compared to analyst estimates of $1.02 billion. During the same period in the previous year, the firm earned $1.45 EPS. The business's revenue for the quarter was up 6.0% compared to the same quarter last year. Plexus has set its Q4 2025 guidance at 1.820-1.970 EPS. On average, equities research analysts expect that Plexus Corp. will post 5.9 earnings per share for the current fiscal year.

About Plexus

Plexus Corp. provides electronic manufacturing services in the United States and internationally. It offers design, develop, supply chain, new product introduction, and manufacturing solutions, as well as sustaining services to companies in the healthcare/life sciences, industrial/commercial, aerospace/defense, and communications market sectors.